Magnesium at a Glance
Magnesium is an essential mineral and the fourth most abundant in the body — about half locked in bone, most of the rest inside cells. It is a cofactor for more than 300 enzymes, including every reaction that handles ATP.
It is also one of the more commonly under-consumed nutrients in Western diets, and it is unusually versatile: the same mineral works as a laxative, a blood-pressure agent and a migraine preventive depending on the form and dose.
What It’s Used For
- Constipation — draws water into the bowel; the basis of magnesium laxatives.
- Blood pressure — lowers blood pressure, most in people who are deficient or already on treatment.
- Blood sugar (type 2 diabetes) — improves glycemic control, with a dose-response relationship.
- Migraine prophylaxis — a recognised migraine preventive.
- Sleep — supports sleep quality, studied mainly in older adults.
- Depression & anxiety — used as an adjunct for mood.
How It Works
Magnesium’s job is mostly structural chemistry: it stabilises ATP, so every enzyme that transfers phosphate needs it present. It also sits in the NMDA receptor channel as a voltage-dependent block, damping excitatory glutamate signalling — the basis of the sleep, migraine and mood effects — and relaxes vascular smooth muscle, which is the blood-pressure route.
The form decides the use. Poorly absorbed salts like oxide stay in the gut, which makes them effective laxatives; better-absorbed forms such as glycinate, citrate and malate are the ones used for anything systemic.
The full trial record is in Pharmacology & Research below.
Pharmacology & Research
Magnesium is an essential mineral and a cofactor for more than 300 enzymes, so true deficiency touches nerve, muscle, cardiovascular and metabolic function broadly. That makes its supplement story two-sided: correcting a deficit has wide effects, but in already-replete people the benefits of extra magnesium are usually modest. The most consistent human data are for blood pressure, blood sugar and migraine prevention — real but small average effects, larger in people who are deficient or already on treatment — plus a dependable osmotic laxative action. Claims for sleep, mood and muscle cramps are popular but rest on thin or largely negative evidence.
Support is an experimental score I’m building — a composite weighted by study type (human > animal > in vitro > review) and study volume. It’s a beta: a fast way to rank strength of evidence at a glance, not a validated metric. Each application links down to its write-up.
Magnesium’s most concrete effect is pharmacological, not nutritional: unabsorbed magnesium salts draw water osmotically into the gut and stimulate motility. A double-blind RCT of magnesium oxide (1.5 g/day, 28 days) significantly improved bowel-movement frequency, stool form and quality of life in chronic constipation versus placebo 11Reference 11RCTA randomised double-blind placebo-controlled trial of magnesium oxide in patients with chronic constipation — randomised controlled trialView study →. This is the same mechanism behind the diarrhea that limits high supplement doses.
Gap: it’s a laxative effect, dose-dependent and shared by most forms — useful for constipation, but not evidence that “more magnesium” benefits an already-replete person systemically 11Reference 11RCTA randomised double-blind placebo-controlled trial of magnesium oxide in patients with chronic constipation — randomised controlled trialView study →.
A 2025 systematic review and meta-analysis of 38 RCTs (n≈2,700, median 365 mg/day) found magnesium lowered systolic blood pressure by about 2.8 mmHg and diastolic by 2.1 mmHg 1Reference 1Meta-analysisMagnesium supplementation and blood pressure — systematic review and meta-analysis of randomised controlled trialsView study →. The effect is larger in people who are hypomagnesemic or already on antihypertensive drugs, and marginal in healthy normotensives 1Reference 1Meta-analysisMagnesium supplementation and blood pressure — systematic review and meta-analysis of randomised controlled trialsView study →.
Gap: the average effect is small and clinically modest; magnesium is an adjunct for at-risk or deficient people, not a stand-alone blood-pressure treatment 1Reference 1Meta-analysisMagnesium supplementation and blood pressure — systematic review and meta-analysis of randomised controlled trialsView study →.
A dose-response meta-analysis of oral magnesium in type 2 diabetes found meaningful improvements in fasting glucose and HbA1c, strongest at around 500 mg/day and in longer trials, and greater in magnesium-deficient patients 2Reference 2Meta-analysisEffects of oral magnesium supplementation on glycaemic control in type 2 diabetes — systematic review and dose-response meta-analysisView study →. Magnesium is a cofactor in insulin signaling and glucose handling, giving the effect a clear mechanism.
Gap: the authors state the evidence is not yet strong enough to guide clinical practice; effects shrink at lower doses and in replete patients 2Reference 2Meta-analysisEffects of oral magnesium supplementation on glycaemic control in type 2 diabetes — systematic review and dose-response meta-analysisView study →.
Migraine is the one neurological use with formal endorsement: professional headache guidelines rate magnesium “probably effective” for prevention, and a 2025 dose-response meta-analysis found supplements reduced attack frequency and monthly migraine days 3Reference 3Meta-analysisEffects of selected dietary supplements on migraine prophylaxis — systematic review and dose-response meta-analysis of randomised controlled trialsView study →. A classic RCT of 600 mg/day magnesium dicitrate cut attack frequency by ~42% versus placebo 4Reference 4RCTProphylaxis of migraine with oral magnesium — a prospective, multicentre, placebo-controlled, double-blind randomised studyView study → — but a similarly sized RCT of a different salt found no benefit and stopped early 5Reference 5RCTMagnesium in the prophylaxis of migraine — a double-blind, placebo-controlled randomised study (null result)View study →.
Gap: RCTs genuinely conflict (salt and dose may matter), certainty is low, and effective doses exceed the supplemental upper limit, so it warrants clinician supervision 3,
A meta-analysis of 7 RCTs in adults with depressive disorder reported a sizeable reduction in depression scores (SMD ≈ −0.92) 6Reference 6Meta-analysisMagnesium supplementation beneficially affects depression in adults with depressive disorder — systematic review and meta-analysis of randomised clinical trialsView study →. For anxiety the signal is thinner and often premenstrual-specific: magnesium eased fluid-retention PMS symptoms on its own 8Reference 8RCTMagnesium supplementation alleviates premenstrual symptoms of fluid retention — randomised controlled crossover trialView study →, but relieved anxiety-related premenstrual symptoms only when combined with vitamin B6 9Reference 9RCTA synergistic effect of a daily supplement of magnesium plus vitamin B6 on anxiety-related premenstrual symptoms — randomised, double-blind, crossover studyView study →.
Gap: the trials are small and heterogeneous, so a −0.9 effect size is very likely inflated relative to what larger studies would show; treat as promising, not proven 6Reference 6Meta-analysisMagnesium supplementation beneficially affects depression in adults with depressive disorder — systematic review and meta-analysis of randomised clinical trialsView study →.
A meta-analysis of 3 RCTs in older adults found magnesium shortened time to fall asleep by about 17 minutes versus placebo, but the trials were rated low quality and total sleep time did not significantly improve 7Reference 7Meta-analysisOral magnesium supplementation for insomnia in older adults — systematic review and meta-analysisView study →. A newer magnesium bisglycinate trial reported an improvement in insomnia severity that was statistically present but very small.
Gap: the sleep evidence is underwhelming and low-quality; any benefit is modest and clearest in people who are deficient 7Reference 7Meta-analysisOral magnesium supplementation for insomnia in older adults — systematic review and meta-analysisView study →.
Mechanisms
| Target / pathway | Effect | Relevant to |
|---|---|---|
| Cofactor for 300+ enzymes (ATP handling, insulin signaling) | normal nerve, muscle & glucose function | blood sugarcrampsgeneral |
| Vascular smooth-muscle relaxation; calcium antagonism | mild vasodilation | blood pressuremigraine |
| NMDA-receptor / neuronal excitability modulation | dampened over-excitation | migrainemoodsleep |
| Osmotic water retention in the gut lumen | softer stool, motility | constipation (and dose-limiting diarrhea) |
Pharmacokinetics
Fractional absorption falls as dose rises — from roughly two-thirds at low intakes to around a tenth at high single doses — because uptake has a saturable active component plus a small constant passive one 14Reference 14Intestinal absorption of magnesium from food and supplements — human physiology studyView study →. The practical upshot is to split larger doses and not expect a big single dose to be fully absorbed. Overall, about 30–40% of dietary magnesium is absorbed 12Reference 12ReviewMagnesium — Fact Sheet for Health Professionals — authoritative review. https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/View study →. Salt form matters mainly at the poorly-absorbed end: magnesium oxide sits around 4% fractional absorption, while chloride, lactate and organic salts are substantially higher and roughly comparable to each other 15Reference 15Clinical trialBioavailability of US commercial magnesium preparations — comparative human studyView study →.
Forms of Magnesium
Supplemental magnesium is sold as many different salts and chelates. They differ in three things that actually matter: elemental magnesium (how much magnesium per gram), absorption, and gut tolerance (how likely they are to loosen stools). Each form below has its own page; the comparison:
| Form | Elemental Mg | Absorption | Gut / laxative | Best for |
|---|---|---|---|---|
| Glycinate | ~14% | organic chelate; well tolerated | low — gentlest | calm, sleep, sensitive guts |
| Citrate | ~16% | good; better than oxide 15Reference 15Clinical trialBioavailability of US commercial magnesium preparations — comparative human studyView study → | moderate (laxative higher up) | general repletion, mild constipation |
| L-threonate | ~8% | marketed for brain delivery | low | cognition claims (weak evidence) |
| Oxide | ~60% | poor (~4%) 15Reference 15Clinical trialBioavailability of US commercial magnesium preparations — comparative human studyView study → | high — a classic laxative | cheap bulk elemental Mg; constipation |
| Malate | ~15% | organic; presumed good | low–moderate | general use (fatigue claims thin) |
| Chloride | ~12% | good 15Reference 15Clinical trialBioavailability of US commercial magnesium preparations — comparative human studyView study → | moderate | repletion |
| Sulfate (Epsom) | ~10% | oral: osmotic laxative | very high | laxative; bath soaks |
| Taurate | ~9% | presumed organic-tier | low | cardiovascular/calm claims (thin) |
The common marketing line that “organic forms absorb better than inorganic” is only half-true: the poorly-absorbed outlier is oxide — inorganic chloride absorbs about as well as organic salts 15Reference 15Clinical trialBioavailability of US commercial magnesium preparations — comparative human studyView study →. Aside from oxide, form differences in absorption are smaller than differences in dose and gut tolerance.
Dosage & Intake
The adult RDA is 310–420 mg/day of elemental magnesium (lower for women, higher for men, rising slightly with age) 12,
Two things to read carefully on any label: doses are quoted as elemental magnesium here (a “500 mg magnesium glycinate” capsule contains far less elemental magnesium than 500 mg), and the supplemental Tolerable Upper Intake Level is 350 mg/day — notably lower than the RDA, because the UL counts only supplements and medications, not food 12,
Safety
Magnesium is one of the safer supplements there is — healthy kidneys simply excrete the excess — so the practical ceiling is your gut, not toxicity. The exception that matters is impaired kidney function, where magnesium can genuinely accumulate.
- Very safe from food. In healthy people the kidneys excrete any excess.
- Fine in pregnancy and lactation within intake guidelines. RDAs are established for both — see the box below.
- Impaired kidney function. Hypermagnesemia — low blood pressure, lethargy, irregular heartbeat — is largely confined to this group and to very high laxative/antacid doses; don’t supplement without medical advice.
- The gut is the dose-limiting effect. Diarrhea, nausea and cramping, worst with oxide, chloride, carbonate and gluconate, and the basis for the 350 mg/day supplemental upper limit.
- Separate from some medicines by at least 2 hours. Magnesium reduces absorption of oral bisphosphonates, tetracyclines and quinolones.
Full Safety & Interactions Detail
Magnesium from food is very safe in healthy people — the kidneys excrete any excess 12Reference 12ReviewMagnesium — Fact Sheet for Health Professionals — authoritative review. https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/View study →.
The dose-limiting effect of supplements is gastrointestinal: diarrhea, nausea and cramping, most common with oxide, chloride, carbonate and gluconate, and the basis for the 350 mg/day supplemental upper limit 12,
Serious toxicity (hypermagnesemia — low blood pressure, lethargy, irregular heartbeat) is largely confined to very high doses from magnesium-containing laxatives/antacids and to people with impaired kidney function, who should not supplement without medical advice 12Reference 12ReviewMagnesium — Fact Sheet for Health Professionals — authoritative review. https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/View study →.
Magnesium can also reduce absorption of some medicines: separate it by at least 2 hours from oral bisphosphonates and certain antibiotics (tetracyclines, quinolones) 12Reference 12ReviewMagnesium — Fact Sheet for Health Professionals — authoritative review. https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/View study →.
Generally recognized as safe within intake guidelines. Magnesium is an essential nutrient with established RDAs in pregnancy and lactation, and food and normal supplemental intakes are considered safe; as with any supplement, high therapeutic doses (e.g. for migraine or as a laxative) should be cleared with a clinician 12,
Dietary Sources
Magnesium is concentrated in seeds, nuts, leafy greens, legumes and unrefined grains (refining strips the magnesium-rich germ and bran); dark chocolate and mineral-rich water also contribute 12Reference 12ReviewMagnesium — Fact Sheet for Health Professionals — authoritative review. https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/View study →.
| Food | Magnesium (per serving) |
|---|---|
| Pumpkin seeds (1 oz) | ~156 mg |
| Chia seeds (1 oz) | ~111 mg |
| Almonds (1 oz) | ~80 mg |
| Spinach, boiled (½ cup) | ~78 mg |
| Cashews (1 oz) | ~74 mg |
| Black beans, cooked (½ cup) | ~60 mg |
| Peanut butter (2 tbsp) | ~49 mg |
Roughly 30–40% of dietary magnesium is absorbed 12Reference 12ReviewMagnesium — Fact Sheet for Health Professionals — authoritative review. https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/View study →.
References
- Argeros Z, Xu X, Bhandari B, Harris K, Touyz RM, Schutte AE. (2025). Magnesium supplementation and blood pressure — systematic review and meta-analysis of randomised controlled trials. Hypertension, 82(11), 1844–1856. https://pubmed.ncbi.nlm.nih.gov/41000008/
- Asbaghi O, Moradi S, Kashkooli S, et al. (2022). Effects of oral magnesium supplementation on glycaemic control in type 2 diabetes — systematic review and dose-response meta-analysis. British Journal of Nutrition, 128(12), 2363–2372. https://pubmed.ncbi.nlm.nih.gov/35045911/
- Talandashti MK, Shahinfar H, Delgarm P, Jazayeri S. (2025). Effects of selected dietary supplements on migraine prophylaxis — systematic review and dose-response meta-analysis of randomised controlled trials. Neurological Sciences, 46(2), 651–670. https://pubmed.ncbi.nlm.nih.gov/39404918/
- Peikert A, Wilimzig C, Köhne-Volland R. (1996). Prophylaxis of migraine with oral magnesium — a prospective, multicentre, placebo-controlled, double-blind randomised study. Cephalalgia, 16(4), 257–263. https://pubmed.ncbi.nlm.nih.gov/8792038/
- Pfaffenrath V, Wessely P, Meyer C, et al. (1996). Magnesium in the prophylaxis of migraine — a double-blind, placebo-controlled randomised study (null result). Cephalalgia, 16(6), 436–440. https://pubmed.ncbi.nlm.nih.gov/8902254/
- Moabedi M, Aliakbari M, Erfanian S, Milajerdi A. (2023). Magnesium supplementation beneficially affects depression in adults with depressive disorder — systematic review and meta-analysis of randomised clinical trials. Frontiers in Psychiatry, 14, 1333261. https://pubmed.ncbi.nlm.nih.gov/38213402/
- Mah J, Pitre T. (2021). Oral magnesium supplementation for insomnia in older adults — systematic review and meta-analysis. BMC Complementary Medicine and Therapies, 21(1), 125. https://pubmed.ncbi.nlm.nih.gov/33865376/
- Walker AF, De Souza MC, Vickers MF, et al. (1998). Magnesium supplementation alleviates premenstrual symptoms of fluid retention — randomised controlled crossover trial. Journal of Women’s Health, 7(9), 1157–1165. https://pubmed.ncbi.nlm.nih.gov/9861593/
- De Souza MC, Walker AF, Robinson PA, Bolland K. (2000). A synergistic effect of a daily supplement of magnesium plus vitamin B6 on anxiety-related premenstrual symptoms — randomised, double-blind, crossover study. Journal of Women’s Health & Gender-Based Medicine, 9(2), 131–139. https://pubmed.ncbi.nlm.nih.gov/10746516/
- Garrison SR, Korownyk CS, Kolber MR, et al. (2020). Magnesium for skeletal muscle cramps — Cochrane systematic review and meta-analysis. Cochrane Database of Systematic Reviews, 9, CD009402. https://pubmed.ncbi.nlm.nih.gov/32956536/
- Mori S, Tomita T, Fujimura K, et al. (2019). A randomised double-blind placebo-controlled trial of magnesium oxide in patients with chronic constipation — randomised controlled trial. Journal of Neurogastroenterology and Motility, 25(4), 563–575. https://pubmed.ncbi.nlm.nih.gov/31587548/
- National Institutes of Health, Office of Dietary Supplements. (2022). Magnesium — Fact Sheet for Health Professionals — authoritative review. https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/
- Institute of Medicine, Food and Nutrition Board. (1997). Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride — DRI report. National Academies Press. https://www.ncbi.nlm.nih.gov/books/NBK109816/
- Fine KD, Santa Ana CA, Porter JL, Fordtran JS. (1991). Intestinal absorption of magnesium from food and supplements — human physiology study. Journal of Clinical Investigation, 88(2), 396–402. https://pubmed.ncbi.nlm.nih.gov/1864954/
- Firoz M, Graber M. (2001). Bioavailability of US commercial magnesium preparations — comparative human study. Magnesium Research, 14(4), 257–262. https://pubmed.ncbi.nlm.nih.gov/11794633/
